Vitamin D3 Market Size is set to gain traction from 2021 to 2027 on account of the growing prevalence of cardiovascular diseases. The rise in the number of vitamin deficient cases has led to growing consumer efforts towards strengthening weak muscles. The mount in the amount of regulatory support across most parts of the globe is another key factor adding to the market growth.
With respect to type, the Vitamin D3 oil market is expected to see notable proceeds during the period 2021 to 2027 due to increasing penetration in face products to repair DNA damages, strengthen and tighten the skin, whilst minimizing inflammation and red undertones. Apart from acting as an immunity booster, vitamin D3 offers multiple health benefits such as strengthening bones and muscles, enhancing heart functions, and assistance in weight loss. Furthermore, the limitations of sunscreen will complement the industry expansion.
Application wise, Vitamin D3 industry demand across supplements is likely to expand at a robust pace owing to the rising instances of child malnourishment. Vitamin D not only assists in the development of teeth and bones but also facilitates proper regulation of the heart. The increasing concerns over the weakening of bones & cartilage tissues will add positive impetus to the progression of the market.
On the basis of end-use, the Vitamin D3 market size from the weight management products segment is slated to rise with the growing consumer emphasis on overall physical health and wellbeing. Given its metabolism-boosting features, Vitamin D3 can be touted as a major component in weight management products. The surge in the number of obese individuals will additionally boost the industry expansion.
In terms of regional bifurcation, the North America vitamin D3 industry is anticipated to attain notable momentum. This is mainly due to the higher cases of chronic diseases, such as diabetes and skin cancer in the region. The growing consumption of alcohol & fast food has paved the path for the rising prevalence of obesity. The region also houses a large number of prominent industry players. The increasing government support and the mounting per capita household incomes are some other ideal contributors to the market proliferation.
The vitamin D3 market players are actively taking up novel product launches, as well as inorganic expansion strategies, like mergers, acquisitions, and partnerships, to strengthen their market foothold while gaining competitive advantages.
For instance, in March 2021, Royal DSM introduced its 3 times faster-acting form of vitamin D for dietary supplements, ampli-D®, in Australia in order to render boosted immune health and vitamin D levels in the bodies of consumers.
Similarly, Lonza launched a vegan formulation, MuscleGuard, which comprises its branded Carnipure L-carnitine, leucine, as well as creatine with vitamin D to offer effective sports nutrition alongside amplified muscle strength and body mass in older subjects.
Thorne Research, GlaxoSmithKline, Cadila Pharmaceutical, Koninklijke DSM N.V., Glanbia, Archer Daniels Midland Company, Nature’s Bounty (Bountiful Co), Cadila Pharmaceutical, Pfizer, Abott Nutrition, and BASF SE, are some of the other major vitamin D3 suppliers operating in the business.
The present COVID-19 outbreak drew an alarming impact on the global economy as it posted a groundbreaking influence on an umpteen number of businesses. However, the market for vitamin D3 grew by heaps and bounds amidst the pandemic as low vitamin D levels caused a significant incline in pneumonia and respiratory tract infections in the affected individuals. Owing to this, the consumption of vitamin D3 supplements is incurring a substantial boost in the treatment of the infection.